Laboratory Products
Transient Bulk Transfection by Flow Electroporation
Oct 04 2010
CCS Cell Culture Service has established a new technology, which is now offered as a custom service to clients within drug discovery industries. By using the MaxCyte® STX™ Scalable Transfection System CCS is able to transfect batches of up to 10 billion cells in less than 30 minutes. Cell lines, primary cells and stem cells are reproducibly and efficiently transfected while maintaining the integrity of the cells for subsequent assays. As a result, bulk quantities of assay-ready frozen instant cells, which are transiently expressing targets of interest can now be rapidly prepared.
“We are very excited about this technology. Difficult targets or target complexes can now be easily addressed in a high-throughput screening scale by using large quantities of validated transiently transfected cells, even in more in vivo-like cellular backgrounds,” commented Dr Oliver Klotzsche, Managing Director of CCS.
“We are very pleased that CCS has decided to acquire the MaxCyte STX. By providing transient bulk transfection as a custom service, CCS enables everybody to benefit from our technology and helps to get it established as an important tool for drug discovery,” stated Douglas Doerfler, President and CEO at MaxCyte.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE